CA2001083A1 - Derive de s-timolol nouveau et procede de preparation correspondant - Google Patents

Derive de s-timolol nouveau et procede de preparation correspondant

Info

Publication number
CA2001083A1
CA2001083A1 CA2001083A CA2001083A CA2001083A1 CA 2001083 A1 CA2001083 A1 CA 2001083A1 CA 2001083 A CA2001083 A CA 2001083A CA 2001083 A CA2001083 A CA 2001083A CA 2001083 A1 CA2001083 A1 CA 2001083A1
Authority
CA
Canada
Prior art keywords
novel
preparation
timolol
derivative
timolol derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2001083A
Other languages
English (en)
Other versions
CA2001083C (fr
Inventor
Markku Peralampi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2001083A1 publication Critical patent/CA2001083A1/fr
Application granted granted Critical
Publication of CA2001083C publication Critical patent/CA2001083C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002001083A 1988-10-20 1989-10-20 Derive de s-timolol nouveau et procede de preparation correspondant Expired - Fee Related CA2001083C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI884838 1988-10-20
FI884838A FI82240C (fi) 1988-10-20 1988-10-20 Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.

Publications (2)

Publication Number Publication Date
CA2001083A1 true CA2001083A1 (fr) 1990-04-20
CA2001083C CA2001083C (fr) 1999-06-15

Family

ID=8527232

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002001083A Expired - Fee Related CA2001083C (fr) 1988-10-20 1989-10-20 Derive de s-timolol nouveau et procede de preparation correspondant

Country Status (12)

Country Link
US (4) US5231095A (fr)
EP (1) EP0440684B1 (fr)
JP (1) JP2949508B2 (fr)
AT (1) ATE112277T1 (fr)
AU (1) AU624431B2 (fr)
CA (1) CA2001083C (fr)
DE (1) DE68918597T2 (fr)
DK (1) DK175377B1 (fr)
FI (1) FI82240C (fr)
NO (1) NO179838C (fr)
NZ (1) NZ231057A (fr)
WO (1) WO1990004592A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496820A (en) * 1988-10-20 1996-03-05 Peraelampi; Markku Ophthalmic use of S-timolol hemihydrate
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
TW208013B (fr) * 1990-03-01 1993-06-21 Daiichi Co Ltd
ES2106852T3 (es) * 1992-07-08 1997-11-16 Santen Oy Composicion oftalmica que contiene hemihidrato de timolol.
US20060143783A1 (en) * 2004-12-15 2006-07-06 Berman Paul K Energy diffusing glove insert
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
AU2008220104B2 (en) 2007-02-28 2012-09-27 Asahi Kasei Pharma Corporation Sulfonamide derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
FI71933C (fi) * 1984-03-30 1989-04-06 Star Oy Ab Nya l-vinsyra-0-monoestrar av 3-morfolino-4-(3'-tert.-butylamino-2'-hydroxipropoxi)-1,2,5-tiadiazol och deras anvaendning saosom mellanprodukter.
JPS60226855A (ja) * 1984-04-26 1985-11-12 Nippon Kayaku Co Ltd Ｎ−ベンジルオキシカルボニル−ｌ−スレオニンアミド・１／２水和物およびその製造法
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.

Also Published As

Publication number Publication date
FI82240B (fi) 1990-10-31
AU624431B2 (en) 1992-06-11
DK72591A (da) 1991-04-19
NO911508L (no) 1991-04-17
DE68918597D1 (de) 1994-11-03
US5354860A (en) 1994-10-11
CA2001083C (fr) 1999-06-15
DK72591D0 (da) 1991-04-19
JPH04502612A (ja) 1992-05-14
NO911508D0 (no) 1991-04-17
JP2949508B2 (ja) 1999-09-13
NZ231057A (en) 1990-11-27
FI884838A0 (fi) 1988-10-20
EP0440684A1 (fr) 1991-08-14
EP0440684B1 (fr) 1994-09-28
FI884838A (fi) 1990-04-21
DE68918597T2 (de) 1995-05-11
WO1990004592A1 (fr) 1990-05-03
ATE112277T1 (de) 1994-10-15
DK175377B1 (da) 2004-09-20
AU4347389A (en) 1990-05-14
US5574035A (en) 1996-11-12
NO179838C (no) 1996-12-27
FI82240C (fi) 1991-02-11
NO179838B (no) 1996-09-16
US5231095A (en) 1993-07-27
US5541184A (en) 1996-07-30

Similar Documents

Publication Publication Date Title
EP0320762A3 (en) Process for the preparation of a chiral, stereorigid metallocen compound
SG45593G (en) A process for the preparation of an oxirane compound
IS1636B (is) Aðferð við framleiðslu á efnasamsetningu sem gerðer úr uppbótarefnum (3-substistuted) og kristalsamböndum (2-oxindole)
AU1237888A (en) Process for the preparation of a thiazepine compound
AU2868789A (en) 1,4-disubstituted-piperidinyl compounds
AU6853187A (en) 1,4-benzoxazine derivatives
AU6110690A (en) Process for the preparation of a polyolefin
AU3548993A (en) Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
AU2779889A (en) Lipophilic (3,5) substituted oxadiazole derivatives
AU8506791A (en) Novel 4-piperidinylcarbonyl derivatives
AU4935390A (en) A novel substituted-acetamide compound and a process for the preparation thereof
HU9200771D0 (en) Process for the production of aryl-1,2,4-triazolyn-5-on derivatives
CA2001083A1 (fr) Derive de s-timolol nouveau et procede de preparation correspondant
AU627880B2 (en) Novel thiomethyl phosphonate derivatives
AU1302088A (en) Process for the preparation of a macrocyclic compound
EP0374410A3 (fr) Acide 2-azabicyclo(2.2.1)hept-5-ène-2-acétique, dérivés de celui-ci et composés apparentés, procédé pour la préparation de ces composés et l'utilisation de ces composés pour la préparation de N-phosphonométhylglycine
EP0371492A3 (en) Process for the preparation of 1,4-dihydropyridine derivatives
GB2216521B (en) Process for the preparation of 1,4-dihydro-pyridine derivatives
CA2038434A1 (fr) Methode de preparation de carbodithioates de piperidine substitues par un groupement fluoromethyle
AU2975089A (en) Novel compounds, process for the preparation thereof and uses thereof
AU3399289A (en) Process for preparing 5-c-hydroxymethyl aldohexose-based compounds
CA2031578A1 (fr) Procede de preparation de composes molluscicides a base de 2,4,5-tribromopyrrole-3-carbonitrile
AU8298787A (en) A process for the preparation of the demalonyl compound of macrolide lactones
AU590431B2 (en) A method for the preparation of 2,4-diamino-3-oxy-6- piperidyl-pyrimidine
AU7644587A (en) A process for the preparation of nitrogen-containing heterocyclic compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20061020